Published on 11 Nov 2022 on Zacks via Yahoo Finance
Phio Pharmaceuticals Corp. (PHIO) Reports Q3 Loss, Lags Revenue Estimates
Phio Pharmaceuticals Corp. (PHIO) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of $0.36. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -172.22%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.19, delivering a surprise of 38.71%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.